Granite Investment Partners’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-4,700
Closed -$476K 304
2015
Q4
$476K Hold
4,700
0.04% 269
2015
Q3
$461K Sell
4,700
-3,600
-43% -$400K 0.04% 267
2015
Q2
$972K Hold
8,300
0.09% 219
2015
Q1
$814K Hold
8,300
0.07% 248
2014
Q4
$782K Hold
8,300
0.09% 248
2014
Q3
$884K Hold
8,300
0.12% 183
2014
Q2
$688K Buy
8,300
+2,420
+41% +$188K 0.1% 186
2014
Q1
$417K Buy
+5,880
New +$461K 0.06% 184

Other funds holding GILD

Granite Investment Partners's GILD Position: Q1 2016 in Review

Granite Investment Partners sold out of Gilead Sciences (GILD) in Q1 2016, closing a stake of 4,700 shares — an estimated $476K sold.

Granite Investment Partners first reported a position in GILD in Q1 2014 and held it in 8 quarters. The position peaked at $972K in Q2 2015. 1,629 funds tracked by Wall St. Rank hold GILD as of Q1 2016.

  • Granite Investment Partners reported no remaining Gilead Sciences position as of Q1 2016 after selling out during the quarter.
  • Granite Investment Partners sold 4,700 Gilead Sciences shares in Q1 2016, an estimated $476K.
  • Granite Investment Partners first reported a position in Gilead Sciences in Q1 2014 and held it in 8 quarters.
  • Granite Investment Partners's Gilead Sciences position peaked at $972K in Q2 2015.
  • 1,629 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2016.

Based on Granite Investment Partners's 13F filing for Q1 2016, filed 27 Apr 2016.